Helsinn

Home > Irish Pharmaceuticals > News > News 2006

20/12/2006	UPDATE ON ALOXI’S 2006 REGISTRATIONS AND LAUNCHES
14/12/2006	HELSINN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR ALOXI® (PALONOSETRON HYDROCHLORIDE) INJECTION FOR THE PREVENTION OF POST OPERATIVE NAUSEA & VOMITING
16/11/2006	Helsinn Healthcare SA Suspends Enrollment of New Patients in Becatecarin
26/10/2006	HELSINN HEALTHCARE AND EKR THERAPEUTICS SIGN AN EXCLUSIVE LICENSE AGREEMENT FOR GELCLAIR® IN NORTH AMERICA
03/10/2006	HELSINN HEALTHCARE’S PARTICIPATION IN THE 31st EDITION OF THE ESMO CONGRESS, ISTANBUL, TURKEY
29/09/2006	HELSINN’S 2nd manufacturing plant for High Potency Active Ingredients (HPAI) ready for production
27/07/2006	HELSINN’S 2nd TIME AT THE 12th INTERNATIONAL PAIN CLINIC CONGRESS, THE WORLD SOCIETY OF PAIN CLINICIANS, Turin, 4-7 July 2006
26/07/2006	Third bay for API manufacturing of Helsinn Advanced Synthesis SA is operative
20/07/2006	THE OUTCOME OF HELSINN’S ACTIVE PARTICIPATION IN THE EULAR 2006 CONGRESS
05/07/2006	HELSINN’S 2006 REGIONAL NIMESULIDE MARKETING MEETINGS
03/07/2006	HELSINN BIREX PHARMACEUTICALS LTD ACHIEVES CPD ACCREDITATION FROM ENGINEERS IRELAND
14/06/2006	HELSINN KEEPS UP ITS PRESENCE AT THE EULAR 2006 CONGRESS WITH ITS ANTI-INFLAMMATORY DRUGS NIMESULIDE AND OXAPROZIN
09/06/2006	HELSINN AT MASCC/ISOO 2006
29/05/2006	HELSINN IS PRESENT AT ASCO 2006 IN ATLANTA, USA, June 2 – 6, 2006
16/05/2006	ANOTHER PROMISING RESULT FOR HELSINN AT THE 5th EUROPEAN ONCOLOGY NURSING SOCIETY SPRING CONVENTION (EONS)
25/04/2006	A POSITIVE OUTCOME FOR HELSINN AT THE 5th EUROPEAN BREAST CANCER CONFERENCE (EBCC) 2006
13/04/2006	HELSINN AT THE EONS 2006 CONVENTION
15/03/2006	ALOXI® AT THE EBCC 2006 CONFERENCE
10/03/2006	HELSINN’S PARTICIPATION AT INFORMEX 2006
10/03/2006	HELSINN AND PFIZER LABORATORIES (PTY) LTD SIGN A LICENSE AGREEMENT FOR THE MARKETING OF ALOXI® IN SOUTH AFRICA
16/02/2006	HELSINN AND BIOVITRUM ENTER A LICENSE AGREEMENT FOR NORDIC MARKETING OF ALOXI®, A DRUG THAT PREVENTS NAUSEA AND VOMITING IN CANCER PATIENTS
02/02/2006	HELSINN AND THERABEL PHARMA ANNOUNCE A LICENSE AGREEMENT FOR ALOXI®
26/01/2006	Helsinn’s Exhibition booth # 321 at INFORMEX 2006
03/01/2006	HELSINN ASSIGNS A RESEARCH GRANT TO THE ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND